one
viabl
option
tackl
grow
resist
antimalari
drug
artemisinin
resort
synthet
drug
multitarget
strategi
involv
use
hybrid
drug
shown
promis
line
new
hybrid
quinolin
pyrimidin
synthes
evalu
antiplasmodi
activ
cq
cq
r
strain
plasmodium
falciparum
depict
activ
nanomolar
rang
found
bind
heme
well
rich
dna
malaria
one
widespread
diseas
besid
tuberculosi
aid
affect
million
peopl
worldwid
result
around
million
causal
everi
year
africa
alon
around
childhood
death
due
malaria
child
die
everi
estim
african
child
averag
episod
malaria
fever
year
four
typic
recogn
plasmodium
speci
caus
diseas
human
plasmodium
falciparum
deadli
children
age
five
lead
mortal
plasmodium
vivax
morbid
prone
respons
latent
infect
hamper
current
control
futur
elimin
effort
develop
drug
resist
common
antimalari
quinolin
antifol
drug
sesquiterpen
lacton
etc
fig
rather
seriou
issu
stimul
consider
research
effort
develop
new
drug
use
differ
approach
molecular
hybrid
approach
quit
attract
strategi
involv
design
new
chemic
entiti
coval
fusion
two
drug
activ
compound
andor
pharmacophor
unit
deriv
known
bioactiv
molecul
complimentari
activ
multipl
pharmacolog
target
multipl
target
strategi
led
design
hybrid
speci
triazin
ferrocen
rhodanin
chalcon
trioxan
isatin
recent
pyrimidin
fig
quinolin
contain
drug
chloroquin
primaquin
fig
known
affect
parasit
metabol
caus
parasit
death
block
polymer
toxic
heme
insolubl
nontox
pigment
hemozoin
result
cell
lysi
parasit
cell
auto
digest
hand
pyrimidinebas
compound
well
known
wide
rang
promis
antivir
antitubercular
antiaid
antinocicept
antifung
antitumor
antimalari
activ
apart
role
nucleic
acid
synthesi
thu
link
quinolin
unit
pyrimidin
might
furnish
conjug
hybrid
capabl
show
use
antimalari
activ
recent
antimalari
activ
quinolineepyrimidin
hybrid
activ
micromolar
nanomolar
rang
report
fig
yet
anoth
report
evalu
quinolineepyrimidin
activ
micromolar
rang
also
report
fix
combin
chloroquin
pyrimethamin
report
pyrimidin
link
quinolin
unit
employ
rather
conform
flexibl
link
coval
core
novel
pyrimidin
carboxyl
hybrid
interact
iron
center
free
heme
within
physiolog
environ
ph
key
step
accumul
heme
select
toxic
parasit
enhanc
possibl
accumul
within
digest
vacuol
via
weakbas
trap
mechan
cq
quinolin
antimalari
attain
high
concentr
insid
compart
develop
novel
class
antimalari
use
pharmacophor
hybrid
approach
motif
hybrid
ironcomplex
moieti
posit
elabor
structureeact
profil
present
addit
new
carboxyl
hybrid
also
report
antimalari
activ
cq
sensit
cq
well
cq
resist
cq
r
strain
final
mechan
action
studi
repres
compound
also
perform
hybrid
synthes
econom
way
use
synthet
approach
outlin
scheme
key
start
compound
one
prepar
nh
cltfa
catalyz
threecompon
biginelli
condens
alkyl
acetoacet
urea
appropri
aldehyd
formyl
equival
deriv
acetonitril
solventfre
reaction
condit
case
subsequ
oxid
use
nitric
acid
readili
furnish
pyrimidinon
upon
chlorin
pocl
yield
nucleophil
substitut
reaction
appropri
turn
prepar
commerci
avail
diaminoalkan
gave
good
yield
tabl
structur
unambigu
establish
basi
spectral
h
nmr
c
nmr
ms
ft
ir
well
microanalyt
analysi
previous
establish
pyrimidin
hybrid
intercept
diaminoalkyl
spacer
show
optimum
potenc
tabl
flexibl
spacer
consist
three
four
carbon
atom
introduct
nitro
substitu
ortho
posit
phenyl
ring
pyrimidin
core
furnish
potent
compound
antimalari
activ
superior
standard
cq
close
artesun
keep
observ
mind
plan
refin
activ
persuas
incorpor
electron
withdraw
substitu
phenyl
pyrimidin
core
well
vari
ester
substitu
also
alter
basic
diaminoalkyl
spacer
vitro
antimalari
screen
new
synthes
compound
reveal
good
moder
activ
nm
rang
test
cq
strain
cq
r
p
falciparum
tabl
although
test
hybrid
activ
standard
drug
viz
cq
asn
interest
sar
drawn
analysi
activ
compound
record
tabl
reveal
replac
ethyl
ester
previous
report
decreas
antimalari
activ
chloroquin
sensit
chloroquin
resist
strain
p
falciparum
howev
comparison
hybrid
ident
butyl
spacer
show
incorpor
isopropyl
ester
pyrimidin
motif
increas
antimalari
activ
cq
strain
wherea
consider
decreas
activ
observ
cq
r
strain
p
falciparum
also
potent
compound
seri
display
increas
antimalari
activ
standard
cq
cq
r
strain
p
falciparum
diaminoalkyl
linker
compound
replac
rel
less
basic
alkoxi
amino
linker
consider
decreas
antimalari
activ
observ
turn
link
decreas
accumul
compound
via
ph
trap
digest
vacuol
unexpect
sinc
basic
alkyl
chain
linker
play
crucial
role
determin
antimalari
activ
class
compound
furthermor
introduct
nitro
substitu
phenyl
ring
posit
pyrimidin
core
creat
result
signific
increas
antiplasmodi
activ
comparison
pchloropfluoro
substitu
moreov
hybrid
lack
substitu
pyrimidin
motif
led
increas
antimalari
activ
cq
well
cq
r
strain
p
falciparum
howev
although
antimalari
activ
superior
less
correspond
phenyl
substitut
analog
well
thu
sar
studi
suggest
substitut
phenyl
group
electron
withdraw
group
alter
basic
linker
lead
better
antimalari
activ
unfortun
compound
suffer
high
clogp
valu
rang
tabl
suggest
fact
possess
limit
aqueou
solubl
howev
seriou
limit
view
recent
advanc
formul
method
compound
evalu
toxic
variou
hela
vero
crfk
hel
mdck
cell
cultur
tabl
si
tabl
toxic
data
reveal
compound
exhibit
high
toxic
low
cc
mdck
cell
cultur
cc
valu
quiet
high
cell
cultur
cc
valu
inhibit
mdck
cell
summar
tabl
indic
strongest
antimalari
compound
mildli
cytotox
tabl
ratio
cytotox
cc
mm
vitro
antimalari
activ
ic
nm
strain
enabl
determin
select
index
si
compound
compound
alkoxi
amino
linker
compound
bear
unsubstitut
pyrimidin
motif
exhibit
high
cc
valu
thu
led
fairli
safe
select
index
valu
tabl
compound
less
basic
alkyl
spacer
display
highest
si
wherea
potent
compound
exhibit
rel
low
si
valu
tabl
vii
felin
corona
viru
fipv
felin
herp
viru
activ
crfk
cell
cultur
tabl
antivir
activ
compound
impress
except
compound
exhibit
rel
low
ec
felin
corona
viru
fipv
felin
herp
viru
crfk
cell
cultur
tabl
quinolin
antimalari
eg
cq
amodiaquin
quinin
act
princip
form
adduct
ferriprotoporphyrin
ix
thu
block
haemozoin
format
studi
evalu
mechan
antimalari
activ
potent
compound
seri
studi
bind
heme
fig
titrat
monomer
heme
also
perform
plasmodi
food
vacuol
ph
use
me
buffer
instead
hepe
ensur
compound
bind
heme
even
acid
ph
stoichiometri
stabl
complex
monomer
heme
ph
establish
job
plot
si
figur
associ
constant
tabl
calcul
analyz
titrat
curv
obtain
ph
use
hypspecea
nonlinear
least
squar
fit
programm
bind
cq
heme
ident
condit
also
determin
similar
manner
result
present
tabl
comparison
tabl
show
associ
constant
complex
form
monomer
heme
log
k
compar
standard
antimalari
drug
cq
log
k
furthermor
decreas
appar
ph
tabl
littl
effect
bind
constant
indic
bind
stronger
even
acid
ph
establish
bind
monomer
heme
h
nmr
titrat
perform
shift
peak
well
peak
intens
note
addit
mol
heme
dissolv
dmso
solut
dmso
od
ml
caus
shift
aromat
proton
signal
fig
indic
bind
heme
addit
heme
led
broaden
peak
equimolar
mmol
solut
hemin
chlorid
analyz
mass
spectromet
depict
intens
molecular
ion
peak
da
fig
correspond
molecular
formula
c
h
clfen
suggest
format
complex
thu
propos
interact
heme
replac
chlorid
atom
hemin
chlorid
coordin
iron
atom
endocycl
quinolin
nitrogen
propos
fig
similar
titrat
dimer
moxo
type
mm
ph
use
standard
procedur
increas
concentr
compound
mm
result
decreas
intens
broad
peak
nm
fig
job
plot
calcul
indic
stoichiometri
stabl
moxo
complex
fig
tabl
associ
constant
log
k
compar
standard
cq
log
k
also
suggest
bind
stronger
moxo
heme
log
k
monomer
heme
log
k
thu
compound
inhibit
hemozoin
format
block
grow
face
heme
result
observ
antimalari
activ
furthermor
bhematin
inhibit
assay
si
tabl
show
correl
antimalari
activ
bhematin
inhibit
also
compound
inhibit
bhematin
format
although
less
standard
cq
mechan
mani
antimalari
drug
cq
quinacrin
quinin
reli
upon
interact
dna
presum
ionic
interact
phosphat
group
dna
proton
amin
addit
interact
aromat
nuclei
drug
nucleotid
base
therefor
dna
bind
properti
hybrid
evalu
use
uvevis
spectrophotomet
fluoresc
spectrophotometri
order
probe
interact
compound
dna
addit
ctdna
mm
buffer
methanol
solut
mm
induc
hyperchrom
shift
absorpt
band
nm
wherea
hypochrom
shift
characterist
quinolin
ring
absorpt
nm
fig
also
bathochrom
shift
nm
observ
absorpt
observ
hyperchrom
well
hypochrom
shift
absorpt
band
upon
addit
dna
result
intercal
ct
dna
suggest
literatur
interc
natur
interact
compound
ct
dna
addit
support
thermal
denatur
experi
intercal
molecul
doubl
helix
known
stabil
dna
thermal
strand
separ
thu
increas
thermal
melt
temperatur
deriv
melt
curv
present
fig
show
increas
c
thermal
melt
temperatur
ct
dna
upon
addit
less
observ
cq
tabl
thu
uvevis
titrat
thermal
denatur
experi
advoc
partial
interc
natur
interact
compound
ct
dna
visual
effect
dna
base
composit
fluoresc
titrat
perform
gcrich
ct
dna
atrich
dna
buffer
methanol
fig
show
decreas
intens
emiss
band
nm
upon
addit
increas
concentr
dna
shift
nm
emiss
band
nm
observ
upon
addit
ct
dna
shift
emiss
band
observ
dna
comparison
bind
constant
ct
dna
log
k
dna
log
k
calcul
titrat
data
use
hypspec
suggest
discrimin
gc
rich
dna
rich
dna
seri
potent
hybrid
antimalari
activ
nanomolar
rang
report
compound
exhibit
lowest
ic
valu
within
seri
cq
cq
r
strain
p
falciparum
hybrid
display
mild
toxic
mdck
cell
cultur
antivir
activ
profil
hybrid
indic
compound
effect
inhibit
felin
corona
viru
felin
herp
viru
mechan
observ
antimalari
activ
establish
term
bind
heme
well
dna
liquid
reagent
driedpurifi
follow
recommend
dri
agent
andor
distil
molecular
siev
thf
dri
nabenzophenon
ketyl
nitrogen
h
nmr
mhz
c
mhz
nmr
spectra
record
cdcl
multinuclear
jeol
spectromet
chemic
shift
report
part
per
million
rel
intern
tetramethylsilan
tm
h
nmr
chloroform
cdcl
c
nmr
mass
spectra
record
depart
chemistri
guru
nanak
dev
univers
amritsar
bruker
lcm
microtof
ii
spectromet
element
analysi
perform
flash
ea
thermo
electron
corpor
analyz
depart
chemistri
guru
nanak
dev
univers
amritsar
result
quot
ir
spectra
record
perkin
elmer
fourier
transform
spectromet
rang
cm
use
kbr
pellet
melt
point
determin
open
capillari
uncorrect
monitor
progress
reaction
comparison
purpos
thin
layer
chromatographi
tlc
perform
precoat
aluminum
sheet
merck
mm
use
appropri
solvent
system
chromatogram
visual
uv
light
column
chromatographi
silica
gel
mesh
employ
eluent
ethyl
acet
hexan
ethyl
acetatemethanol
mixtur
steadi
state
fluoresc
experi
carri
perkin
elmer
fluoresc
spectromet
ambient
temperatur
uvevis
spectral
studi
conduct
shimadzu
pc
spectrophotomet
quartz
cuvett
path
length
cm
absorpt
spectra
record
nm
cell
holder
spectrophotomet
thermost
c
consist
record
stir
solut
mmol
potassium
carbon
mmol
dri
thf
ml
solut
appropri
mmol
dri
thf
ml
ad
reaction
mixtur
stir
h
room
temperatur
reaction
mixtur
filter
thf
remov
vacuum
residu
purifi
column
chromatographi
use
meoh
ethyl
acet
eluent
obtain
correspond
recrystal
dcmhexan
use
procedur
follow
compound
isol
optim
structur
see
figur
stir
solut
appropri
dri
acetonitril
ml
mixtur
molar
ratio
potassium
carbon
dri
acetonitril
ad
reaction
mixtur
reflux
h
filter
acetonitril
remov
vacuum
residu
purifi
column
chromatographi
use
meohethyl
acet
eluent
give
recrystal
dcmhexan
materi
method
test
sampl
test
triplic
one
two
separ
occas
chloroquin
sensit
cq
strain
p
falciparum
continu
vitro
cultur
asexu
erythrocyt
stage
p
falciparum
maintain
use
modifi
method
trager
jensen
quantit
assess
antiplasmodi
activ
vitro
determin
via
parasit
lactat
dehydrogenas
assay
use
modifi
method
describ
makler
et
al
test
sampl
prepar
mgml
stock
solut
dmso
sonic
enhanc
solubl
sampl
test
suspens
complet
dissolv
stock
solut
store
c
dilut
prepar
day
experi
chloroquin
cq
use
refer
drug
experi
test
sampl
initi
test
three
concentr
mgml
mgml
mgml
determin
start
concentr
full
doseerespons
assay
cq
test
three
concentr
name
ngml
ngml
ngml
full
doseerespons
perform
compound
determin
concentr
inhibit
parasit
growth
ic
valu
test
sampl
test
start
concentr
mgml
serial
dilut
complet
medium
give
concentr
lowest
concentr
mgml
dilut
techniqu
use
sampl
cq
test
start
concentr
ngml
sever
compound
test
start
concentr
ngml
highest
concentr
solvent
parasit
expos
measur
effect
parasit
viabil
data
shown
ic
valu
obtain
use
nonlinear
doseerespons
curv
fit
analysi
via
graph
pad
prism
softwar
cytotox
determin
expos
differ
concentr
sampl
vero
hel
hela
mdck
cell
antivir
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
g
vaccinia
viru
vesicular
stomat
viru
vero
coxsacki
punta
toro
viru
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
mdck
influenza
b
viru
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
cell
cultur
inhibitori
ccid
viru
ccid
viru
dose
infect
cell
cultur
presenc
vari
concentr
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
